The commonest cause of thrombocytopenia in childhood is idiopathic thrombocytopenic purpura, but occasionally it is part of a more generalized autoimmune disease. We report a child presenting with thrombocytopenia who went on to show clinical and biochemical features of systemic lupus erythematosus (SLE), including the presence of a circulating anticoagulant.
Case report
A I3·year·old girl presented with severe, recurrent nose bleeds. Examination showed pallor with a generalized petechial rash. There was no significant lymphadenopathy or hepatosplenomegaly. Initial investigation showed her haemoglobin to be 6.5 g/dl, white cell count 4.5 x 10 9 /1 and platelet count 6 x 10 9 /1. Red cell indices were compatible with chronic blood loss, and bone marrow examination showed plentiful megakaryocytes with no evidence of malignancy. Platelet antibodies were subsequently demonstrated in the patient's serum. A diagnosis of idiopathic thrombocytopenic purpura was made and treatment with red cell transfusion and prednisolone (2 mg/kg/per day) started.
The platelet count responded to prednisolone, increasing to 130000 x 10 9 /1. However when the prednisolone was discontinued after two weeks she developed pyrexia, generalized joint pains and recurrenee of her petechial rash. The platelet count fell to 7 x 10 9 /1. The ESR was elevated at 68 mm/h and clotting times were abnormal. The prothrombin time was 13 seconds (control 13.5 seconds), the partial thromboplastin time 46 seconds (control 36 seconds) and the thrombin time 11 seconds (control 11 seconds). Direct Coombs' test was negative. An immediate acting inhibitor was demonstrated when plasma was mixed with a normal control, and that this was the lupus anticoagulant was confirmed by the tissue thromboplastin inhibition test. Autoantibody screen showed her to be antinuclear factor positive, 1/1280, with DNA binding of 34% (normal 0-10%). Anticardiolipin antibodies were positive (both IgG and IgM), serum complement levels were reduced, C3 68% of normal and C4 40% of normal serum levels. Serum immunoglobulins were normal. A diagnosis of SLE was made and treatment reinstituted with prednisolone (2 mg/kg/day). How-ever, it proved impossible to maintain a satisfactory platelet count despite the addition of azathioprine (2 mg/kg/day). A transient response was seen following intravenous immunoglobulin (0.5 g/kg/day for 5 days}'. Eight months after her initial presentation the patient underwent splenectomy, She has subsequently maintained a normal platelet count in the range 200-300 x 10 9 /1 without any specific therapy.
Although her anticardiolipin antibodies are now negative, the antinuclear factor remains positive and the lupus anticoagulant is still present.
Discussion
The lupus anticoagulant" has only rarely been described in childhoods:". It is more frequently associated with clinical manifestations ofthrombosis than of bleeding, unless it occurs in association with thrombocytopenia, as in the present case, The association between anticardiolipin antibodies and thrombocytopenia has been well described in adult practice", as has the association between anticardiolipin antibodies and lupus anticoagulant". It is thought that the association of these phenomena may represent multiple specificities of an antiphospholipid antibody acting against cardiolipin, platelet wall phospholipid and the phospholipid component of the prothrombin activator complex.
In paediatric practice the diagnosis ofautoimmune thrombocytopenic purpura is frequently made on the basis of bone marrow findings and on the presence of platelet antibodies. Full immunological screening is not usually undertaken, particularly in younger chilo dren. However, in young adults thrombocytopenia is recognized as a common presentation of SLE and it may be that early cases of SLE presenting in childhood are being missed. It would seem reasonable to screen patients over the age of ten years, presenting with thrombocytopenia, for immune deficiency and SLE.
